Current  	Current  	 JJ	O
and  	and  	 CC	O
future  	future  	 JJ	O
medical  	medical  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
for  	for  	 IN	I-NP
menometrorrhagia  	menometrorrhagia  	 NN	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
premenopause  	premenopause  	 FW	B-NP
Excessive  	Excessive  	 FW	I-NP
menstrual  	menstrual  	 FW	I-NP
bleeding  	bleeding  	 FW	O
reflects  	reflects  	 FW	O
aberrant  	aberrant  	 FW	O
angiogenesis 	angiogenesis 	 FW	B-NP
,  	,  	 ,	O
generally  	generally  	 RB	O
due  	due  	 JJ	O
to  	to  	 TO	O
submucosal  	submucosal  	 VB	O
myomas  	myomas  	 NNS	B-NP
and  	and  	 CC	O
endometrial  	endometrial  	 JJ	B-NP
polyps 	polyps 	 NNS	I-NP
,  	,  	 ,	O
although  	although  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
also  	also  	 RB	O
frequently  	frequently  	 RB	O
observed  	observed  	 VBN	O
with  	with  	 IN	O
long-term  	long-term  	 JJ	O
progestin-only  	progestin-only  	 JJ	B-NP
contraception 	contraception 	 NN	I-NP
,  	,  	 ,	O
impaired  	impaired  	 JJ	O
haemostasis  	haemostasis  	 NN	B-NP
and  	and  	 CC	O
hormonal  	hormonal  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
.  	.  	 .	O
Surgery  	Surgery  	 NN	O
( 	( 	 -LRB-	O
hysterectomy 	hysterectomy 	 UH	B-NP
,  	,  	 ,	O
endometrial  	endometrial  	 JJ	B-NP
ablation 	ablation 	 NN	I-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
used  	used  	 VBN	O
too  	too  	 RB	O
frequently 	frequently 	 RB	O
.  	.  	 .	O
Uterine  	Uterine  	 JJ	B-NP
artery  	artery  	 NN	I-NP
embolisation  	embolisation  	 NN	I-NP
is  	is  	 VBZ	O
also  	also  	 RB	O
an  	an  	 DT	O
option  	option  	 NN	O
for  	for  	 IN	O
myomas 	myomas 	 NN	B-NP
.  	.  	 .	O
Medical  	Medical  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
include  	include  	 VBP	O
combined  	combined  	 VBN	O
oral  	oral  	 JJ	B-NP
contraception 	contraception 	 NN	I-NP
,  	,  	 ,	O
progestins  	progestins  	 NN	B-NP
and  	and  	 CC	O
levonorgestrel-releasing  	levonorgestrel-releasing  	 NNP	B-NP
Intrauterine  	Intrauterine  	 NNP	I-NP
System 	System 	 NNP	I-NP
.  	.  	 .	O
Gonadotropin-releasing  	Gonadotropin-releasing  	 JJ	B-NP
hormone  	hormone  	 NN	I-NP
agonists  	agonists  	 NNS	I-NP
provide  	provide  	 VBP	O
significant  	significant  	 JJ	O
improvements  	improvements  	 NNS	B-NP
in  	in  	 IN	O
bleeding  	bleeding  	 VBG	O
for  	for  	 IN	O
myomas 	myomas 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
decrease  	decrease  	 VB	O
estrogen  	estrogen  	 JJ	B-NP
secretion  	secretion  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g.  	e.g.  	 CD	O
hot  	hot  	 JJ	O
flushes 	flushes 	 NN	O
,  	,  	 ,	O
decreased  	decreased  	 VBD	B-NP
bone  	bone  	 JJ	I-NP
mass 	mass 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Progestins 	Progestins 	 NNP	B-NP
,  	,  	 ,	O
although  	although  	 IN	O
used  	used  	 VBN	O
widely 	widely 	 RB	O
,  	,  	 ,	O
remain  	remain  	 VBP	O
poorly  	poorly  	 RB	O
effective  	effective  	 JJ	O
as  	as  	 IN	O
they  	they  	 PRP	O
promote  	promote  	 VBP	O
myoma  	myoma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
growth 	growth 	 NN	I-NP
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
Selective  	Selective  	 NNP	B-NP
Progesterone  	Progesterone  	 NNP	I-NP
Receptor  	Receptor  	 NNP	I-NP
Modulators  	Modulators  	 NNP	I-NP
( 	( 	 -LRB-	O
SPRMs 	SPRMs 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
induce  	induce  	 VB	O
amenorrhea  	amenorrhea  	 FW	B-NP
whilst  	whilst  	 FW	I-NP
maintaining  	maintaining  	 FW	I-NP
endogenous  	endogenous  	 FW	I-NP
estrogen  	estrogen  	 FW	I-NP
secretion 	secretion 	 FW	I-NP
.  	.  	 .	O
Phase  	Phase  	 NNP	O
II  	II  	 NNP	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
also  	also  	 RB	O
demonstrated  	demonstrated  	 VBD	O
decreased  	decreased  	 VBN	O
fibroid  	fibroid  	 JJ	B-NP
size  	size  	 NN	I-NP
in  	in  	 IN	O
SPRM-treated  	SPRM-treated  	 JJ	B-NP
women 	women 	 NNS	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
amenorrhea  	amenorrhea  	 NN	B-NP
observed  	observed  	 VBD	O
after  	after  	 IN	O
SPRM  	SPRM  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
is  	is  	 VBZ	O
still  	still  	 RB	O
poorly  	poorly  	 RB	O
understood 	understood 	 VBN	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
control  	control  	 VB	O
uterine  	uterine  	 JJ	B-NP
bleeding  	bleeding  	 NN	I-NP
via  	via  	 IN	O
a  	a  	 DT	O
direct  	direct  	 JJ	O
effect  	effect  	 NN	O
on  	on  	 IN	O
endometrial  	endometrial  	 JJ	B-NP
blood  	blood  	 NN	I-NP
vessels 	vessels 	 NNS	I-NP
.  	.  	 .	O
Suppression  	Suppression  	 NN	O
of  	of  	 IN	O
bleeding  	bleeding  	 VBG	O
in  	in  	 IN	O
women  	women  	 NNS	O
with  	with  	 IN	O
uterine  	uterine  	 JJ	B-NP
fibroids  	fibroids  	 NNS	I-NP
receiving  	receiving  	 VBG	I-NP
SPRMs  	SPRMs  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
moderate  	moderate  	 JJ	O
reductions  	reductions  	 NNS	O
in  	in  	 IN	O
uterine  	uterine  	 JJ	B-NP
artery  	artery  	 NN	I-NP
blood  	blood  	 NN	I-NP
flow 	flow 	 NN	I-NP
,  	,  	 ,	O
without  	without  	 IN	O
major  	major  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
angiogenic  	angiogenic  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
extracellular  	extracellular  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
composition 	composition 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
clear  	clear  	 JJ	O
difference  	difference  	 NN	O
to  	to  	 TO	O
modifications  	modifications  	 VB	B-NP
observed  	observed  	 VBN	O
with  	with  	 IN	O
progestins 	progestins 	 NN	B-NP
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
major  	major  	 JJ	O
progress  	progress  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
excessive  	excessive  	 JJ	B-NP
menstrual  	menstrual  	 JJ	I-NP
bleeding 	bleeding 	 NN	I-NP
.  	.  	 .	O
